BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2427904)

  • 1. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodilution therapy of acute inner ear damage].
    Pilgramm M
    Acta Med Austriaca; 1991; 18 Suppl 1():60-2. PubMed ID: 1719734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
    Kiesewetter H; Jung F; Blume J; Gerhards M
    Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized double-blind study of therapy of sudden deafness: initial results].
    Desloovere C; Meyer-Breiting E; von Ilberg C
    HNO; 1988 Oct; 36(10):417-22. PubMed ID: 2466024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
    Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
    Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
    Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40].
    Schneider R; Hacke W; Kiesewetter H; Jung F
    Fortschr Med; 1985 Nov; 103(44):1031-4. PubMed ID: 2416658
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus. A literature survey.
    Lamm K; Lamm H; Arnold W
    Adv Otorhinolaryngol; 1998; 54():86-99. PubMed ID: 9547879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
    Ehrly AM; Seebens H; Saeger-Lorenz K
    Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Need for rheologically active, vasoactive and metabolically active substances in the initial treatment of acute acoustic trauma].
    Pilgramm M; Schumann K
    HNO; 1986 Oct; 34(10):424-8. PubMed ID: 2432041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?
    Collins JA; Litwin MS; Lutz H; Klose R; Ring J; Thorén L; Tschirren B; Lundsgaard-Hansen P
    Vox Sang; 1979; 36(1):39-49. PubMed ID: 85370
    [No Abstract]   [Full Text] [Related]  

  • 13. On haemodilution therapy for patients with sudden loss of hearing: clinical and rheological results.
    Wilhelm HJ; Jung F; Kiesewetter H; Recktenwald C
    Klin Wochenschr; 1986 Oct; 64(20):1058-61. PubMed ID: 2431196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)].
    Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H
    Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antishock blood substitute based on hydroxyethyl starch].
    Polushina TV; Prostakova TM; Bogino NA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimental study on the effect of plasma expanders on blood coagulability.
    Narita T; Matsumoto I; Kumazawa T; Ikezono E
    Bull Tokyo Med Dent Univ; 1979 Mar; 26(1):25-32. PubMed ID: 85502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and animal experiment studies to optimise the therapy for acute acoustic trauma.
    Pilgramm M
    Scand Audiol Suppl; 1991; 34():103-22. PubMed ID: 1842458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of low molecular hydroxyethyl starch (HES) on the kidney -- a comparison with low molecular dextran].
    Yamasaki H
    Masui; 1975 Jun; 24(6):580-600. PubMed ID: 51106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.